Futamura-Takahashi, Junko published the artcileStructure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitors, Name: O-Isobutylhydroxylamine hydrochloride, the publication is Bioorganic & Medicinal Chemistry Letters (2018), 28(2), 188-192, database is CAplus and MEDLINE.
Based on insight from the x-ray crystal structure of human chymase in complex with compound 1, a lactam carbonyl of the diazepane core was exchanged with O-substituted oxyimino group, leading to amidoxime derivatives This modification resulted in highly potent chymase inhibitors, such as O-phenylamidoxime I. X-ray crystal structure anal. indicated that compound I induced movement of the Leu99 and Tyr94 side chains at the S2 site, and the increase in inhibitory activity of O-Ph amidoxime derivatives suggested that the O-Ph moiety interacted with the Tyr94 residue. Surface plasmon resonance experiments showed that compound I had slower association and dissociation kinetics and the calculated residence time of compound I to human chymase was extended compared to that of amide compound 1.
Bioorganic & Medicinal Chemistry Letters published new progress about 6084-58-8. 6084-58-8 belongs to catalysis-chemistry, auxiliary class Salt,Amine,Aliphatic hydrocarbon chain, name is O-Isobutylhydroxylamine hydrochloride, and the molecular formula is C4H12ClNO, Name: O-Isobutylhydroxylamine hydrochloride.
Referemce:
https://courses.lumenlearning.com/boundless-chemistry/chapter/catalysis/,
Catalysis – Wikipedia